Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

New York, New York 10021


The purpose of this study is to find out the safety and feasibility of weekly topotecan consolidation therapy in patients with ovarian cancer.

Study summary:

Patients with Stage IIIC and IV optimally-debulked ovarian cancer will be treated with 6 cycles (every 3 weeks) of carboplatin (AUC 5) and paclitaxel (175 mg/m2). Patients who demonstrate a complete clinical response to this regimen will then be treated with topotecan consolidation (4 mg/m2 weekly x 8 weeks for one cycle followed by a break in the 9th week) for a maximum of 3 cycles. Primary endpoints will be toxicity and the determination of the appropriate dose, schedule, and duration of topotecan for further consolidation trials.


Inclusion Criteria: - Patients must have a histopathologic diagnosis of epithelial ovarian cancer. - Patients must have completed front-line chemotherapy and be clinically NED (CA 125 <35, negative CT scan, negative physical exam). - Patients may have a second look laparoscopy, however, there must be no gross disease present (microscopic disease or pathologically negative). - Patients must not have had other myelosuppressive therapy within four weeks of initiating topotecan therapy. - Topotecan treatment must begin within 10 weeks following last cycle of initial chemotherapy. - Patients may have had only one prior chemotherapy regimen. Exclusion Criteria: - Patients with a concomitant malignancy other than squamous cell or basal cell skin cancer. - Patients who are pregnant or breast-feeding.



Primary Contact:

Principal Investigator
Thomas Caputo, M.D.
Weill Medical College of Cornell University

Backup Contact:


Location Contact:

New York, New York 10021
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: November 18, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.